Fact CheckerSign in

NCT07745153Completed

Novel Abdominal Compression Positioning Technique for Respiratory Motion Management in Liver Tumors

Source: ClinicalTrials.gov · Last updated 4 Aug 2026

Brief summary (registry, in English)

1. Research Background The background of this study centers on stereotactic body radiation therapy (SBRT), an advanced form of radiotherapy that is short in duration, highly effective, and easy for patients to comply with. However, even small breathing movements can reduce its precision. Abdominal compression devices have been proven to reduce respiratory motion and are now widely used in clinical practice. This study aims to determine whether a novel abdominal compression positioning technique can control tumor motion as effectively as current abdominal compression devices, whether it works better than traditional thermoplastic masks, and whether it can offer meaningful benefits to patients undergoing radiotherapy. These questions remain to be explored. 2. Study Objectives The purpose of this study is to investigate how different immobilization devices affect the respiratory motion of liver tumors, in order to better assist with target delineation and the delivery of stereotactic body radiation therapy.

Status (registry)
Completed
Study type
Observational
Enrollment
120 (actual)
First submitted
25 Jul 2026
Start date
Jan 2025
Primary completion date
Jul 2026
Lead sponsor
Southern Medical University, China
NCT number
NCT07745153

What you commit to

  • Study type: Observational
  • Participants enrolled: 120
  • From Jan 2025 to the primary completion date, Jul 2026
  • 1 site in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Other illness

  • Discontinuation of radiotherapy or failure to complete the radiotherapy plan as prescribed.
    • Presence of serious complications or comorbidities that may affect safety.

Who the study is looking for

  • Voluntarily signed informed consent.
    • Age ≥ 18 years.
    • Patients who require radiotherapy for liver cancer, as determined by the treating physician.
    • Life expectancy \> 3 months.

Age in the registry: 18 years to - · Sex: All · Does not accept healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (1)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
Department of Radiation Oncology, Nanfang Hospital, Southern Medical University, Guangzhou, Guangdong, People's Republic of China
Coordinator of this site? Confirm its status
GuangzhouChinaUnknown status

This page is information, not medical advice. Discuss any trial with your doctor.